13
Views
4
CrossRef citations to date
0
Altmetric
Original Article

The Rationale of Therapy with Mitoxantrone in Non-Hodgkin's Lymphoma

Pages 63-69 | Received 01 Jun 1992, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

T. Chisesi, P. Polistena, A. Contu, P. Coser, L. Indrizzi, P. Leoni, I. Majolino, A. Porcellini, L. Salvagno, G. Zambaldi, V. Rizzoli, A. M. Congiu & G. Santini. (2001) Cemp, A Mitoxantrone Containing Combination, in the Treatment of Intermediate and High Grade Non-Hodgkin's Lymphoma: an Effective and Non Toxic Therapeutic Alternative for Adult and Elderly Patients: On behalf of Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG). Leukemia & Lymphoma 41:1-2, pages 125-136.
Read now

Articles from other publishers (3)

Nicholas Di Bella, Craig Reynolds, David Faragher, Joseph Muscato, Kristi A. Boehm & Lina Asmar. (2005) An open‐label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low‐grade non‐Hodgkin lymphoma. Cancer 103:5, pages 978-984.
Crossref
A. FossåA. SantoroW. HiddemannL. TruemperN. NiederleS. BuksmauiG. BonadonnaS. SeeberM. R. Nowrousian. (1999) Gemcitabine as a Single Agent in the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma. Journal of Clinical Oncology 17:12, pages 3786-3792.
Crossref
M.J. Kersten, T.J. Verduyn, P. Reiss, L.M. Evers, F. de Wolf & M.H.J. van Oers. (1998) Treatment of AIDS-related non-Hodgkin’s lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: Clinical outcome and effect on HIV-1 viral load. Annals of Oncology 9:10, pages 1135-1138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.